Abiopharma

🔍 Giacin Judith A. (Executive)

Company: Princeton Bancorp, Inc. (BPRN)

Report Date: 2026-06-12

Detailed Transactions and Holdings:

• Acquired 177 shares of Phantom stock (Derivative)
  Date: 2026-06-12 | Code: I | equity_swap_involved: false | shares_owned_after: 5,332.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 23 shares of Phantom stock (Derivative)
  Date: 2026-06-15 | Code: I | equity_swap_involved: false | shares_owned_after: 5,355.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 331 shares of Phantom stock (Derivative)
  Date: 2026-06-16 | Code: I | equity_swap_involved: false | shares_owned_after: 5,686.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: Acquired under the issuer's Non-Employee Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of BPRN common stock. The shares of phantom stock become payable, in cash or common stock, at the election of the reporting person, upon the reporting person's termination of service as a director.